Member Info for shatter

Or is it confirming the Novartis deal ?

Expect the sp to shift about a little in the run up to Novartis's news. You will hear all manner of hype in the interim. How much of the news is built in already is anyone's guess? The 3 billion shares in issue is always going to be a concern and their own R&d is lacklustre. If they can offload these trials and fully concentrate on the manufacturing side, assuming all goes well on the Novartis side, then this company has transformed. Gl.

Get you.... ooohhhhhhh aahhhhhhhh..

Made me chuckle and very accurate.....

Won't filter you because I love listening to drivel, ramping and old news not to mention the repetition. Bless.xo

A lot of very small 2000 buys going through . Fun and games. Back to the 8's soon.

Very healthy volume this morning.

All looking good. Close to the 52 week high. Would be great to break out of this trading range..

Magic, what is your understanding of soon? In a short time, shortly, presently, in the near future, before long, in a little while, in a minute, in a moment, in an instant, in a twinkling, in the twinkling of an eye, before you know it, any minute (now), any day (now), any time (now) :-) No need to ramp. Soon could be a couple of months !

There is a very tight spread at the moment which sometimes confuses the issue. Suspect we will remain in and around the 8's, with the odd blip, until Novartis get the hoped for result .

One could argue or one could read the Vulpes website. Hehe

Yeah, administering drugs to patients should only take a few weeks at most. It's the legal guys that drag it out for years.

Yep, definitely a write off. Only question now is ' when do they pull the pin?' Manufacturing has been a complete disaster, orders? What orders ? Not worth selling now . Market capital of 34 million and Rm2 needs substantially more to keep going. The ball was dropped a long time ago and there ain't no bounce...gl all..

Voice of reason..recommended.

Down 75% now so will stay to the end.. only consolation is the management stand to lose if this goes t:ts up :-)

Looking better already ;-)

There are expert oncologists who are predicting that this may be short lived for Novartis and Oxb, perhaps only 3-4 years, before new and improved cart gene therapies get approval . Hence speed is of the essence. This will have a bearing on the present and future sp.... Comparing Oxb to Lehham Brothers.. tut tut. Oxb ain't going bust anytime soon ! Any director buys and sells at the moment will have a profound impact on the sp. Oxb's r & d is treading water . Offloading these would be a bonus if possible and concentrate on the manufacturing.. Oxb's sp is never going to be anything other than baffling. The refinancing of the loan is a bonus but seems to have been lost in the recent raft of rns's.

What about posting when you are sober :-)

You made me chuckle, cheers. Maybe he is 23 years old with a student loan he needs to clear. Comparing Oxb to Lehman Brothers says it all !!!! Bless.

The chief scientific officer exercised almost 1.5 million share options and then sold them all. The whole shebang, the whole nine yards. What's so difficult to understand ? 150,000 shares at possibly 3p isn't exactly a fortune. Perhaps he knows something we don't.. perhaps he's magical- Trevor !